Skip to main content
SpringerLink
Log in

Metastases and Recurrence of Colorectal Cancer: Diagnostic Role of Immunoscintigraphy

  • Chapter
Colorectal Cancer

Part of the book series: Methods of Cancer Diagnosis, Therapy, and Prognosis ((HAYAT,volume 4))

  • 2102 Accesses

Up to almost a half of all patients who undergo surgical resection of primary color-ectal carcinoma can be expected to get recurrent or metastatic disease, predomi-natly within the first 2 postoperative years (Murphy et al., 1995). However, if the metastases and recurrences are identified before symptoms become evident, oppor tunities for a positive clinical outcome are enhanced. Barium enema examination and colonoscopy are two common modalities used in diagnosis of colorectal cancer, the latter being considered as a gold standard. Presently, advanced traditional and newly developed imaging techniques are also avail able. They are useful in staging the extent of such malignant tumors, including detection of their metastases and recurrences.

Anatomical imaging techniques, such as ultrasonography (US), computed tomo graphy (CT), and magnetic resonance imaging (MRI), are the ones mostly used. Thus, for local staging, superficial tumors are best staged using endorectal US, which also provides an assessment of the tumor ingrowth into the rectal wall layers. More advanced local tumors are best imaged using MRI. Computed tomography is not very accurate in early detection and diffe rentiation of a recurrence of colorectal carcinoma due to distorted local anatomy after surgery as well as in the case of radia tion changes. On the other hand, clinical value of virtual colonoscopy, performed by new generation of CTs is still under investigation. As far as prediction of nodal status is concerned, none of the three men tioned imaging modalities can be reliably used in clinical decision making. This is because many affected lymph nodes are bellow 1 cm in diameter; thus, explaining poor sensitivity of these techiniques. Only MRI using a lymph node specific contrast seems promising in the detection of nodal disease. For the detection of distant metas-tases transabdominal US is often the first choice for liver examination, and develop ment of contrast agents for this technique has significantly increased its potentials in detecting focal liver lesions. Chest X-ray is also used as one of the primary diagnos tic tools. However, multidetector CT is the mainstay of staging and follow-up of these patients, because it provides good cover age of the liver, the complete abdomen and the chest in one session. MRI is commonly used as the definitive imaging modality in detecting and characterizing liver lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Artiko, V., Obradović, V., Davidović, B., Petrović, N., Petrović, M., Krivokapić, Z., Kecmanović, D., PeÅ¡ko, P., Djukić, V., Milosavljević, T., Adanja, G., and Vlajković, M. 2003. Radioimmunodetection of colorectal carcinoma. Hepatogastroenterology 50: 1029–1031.

    PubMed  CAS  Google Scholar 

  • Bares, R., Fass, J., Weiller, G., Wolter, S., Kleinhans, S., Truong, S., Bull, U., and Schumpelick, V. 1989. Clinical significance of immunoscintigraphy for the diagnosis and treatment of gastrointestinal malignant tumors. Onkologie 12: 13–18.

    Article  PubMed  Google Scholar 

  • Baum, R.P., Lorenz, M., Hottenrott, C., Albrecht, M., Senekowitsch, R., Happ, J., Hertel, A., Spitz, J., and Hor, G. 1988. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19–9, and CA 125. Int. J. Biol. Markers 3: 177–184.

    PubMed  CAS  Google Scholar 

  • Behr, T.M., Goldenberg, D.M., Scheele, J.R., Wolf, F.G., and Becker, W. 1997. Clinical relevance of immunoscintigraphy with 99 mTc-labelled anti-CEA antigen-binding fragments in the follow-up of patients with colorectal carcinoma. Assessment of surgical resectability with a combination of conventional imaging methods. Dtsch. Med. Wochenschr. 122: 463–470.

    Article  PubMed  CAS  Google Scholar 

  • Bischof-Delaloye, A., Delaloye, B., Buchegger, F., Gilgien, W., Studer, A., Curchod, S., Givel, J.C., Mosimann, F., Pettavel, J., and Mach, J.P. 1989. Clinical value of immunoscintigraphy in color-ectal carcinoma patients: a prospective study. J. Nucl. Med. 30: 1646–1656.

    PubMed  CAS  Google Scholar 

  • Buraggi, G., Callegaro, L., Turrin, A., Gennari, L., Bombardieri, E., Mariani, G., Deleide, G., Dovis, M., Gasparini, M., and Doci, R. 1987. Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody. Cancer Detect. Prev. 10: 335–345.

    PubMed  CAS  Google Scholar 

  • Chatal, J.F., Saccavini, J.C., Fumoleau, P., Douillard, J.Y., Curtet, C., Kremer, M., Le Mevel, B., and Koprowski, H. 1984. Immunoscintigraphy of colon carcinoma. J. Nucl. Med. 25: 307–314.

    PubMed  CAS  Google Scholar 

  • Chetanneau, A., Baum, R.P., Lehur, P.A., Liehn, J.C., Perkins, A.C., Bares, R., Bourguet, P., Herry, J.Y., Saccavini, J.C., and Chatal, J.F. 1990. Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19–9 monoclonal antibody F(ab')2 fragments. Eur.J. Nucl. Med. 17: 223–229.

    Article  PubMed  CAS  Google Scholar 

  • Doerr, R.J., Abdel-Nabi, H., Krag, D., and Mitchell, E. 1991. Radiolabeled antibody imaging in the management of colorectal cancer: results of a mul-ticenter clinical study. Ann. Surg. 214: 118–124.

    Article  PubMed  CAS  Google Scholar 

  • Dominguez, J.M., Wolff, B.G., Nelson, H., Forstrom, L.A., and Mullan, B.P. 1996. 111In-CYT-103 scanning in recurrent colorectal cancer-does it affect standard management? Dis. Colon Rectum. 39: 514–519.

    Article  PubMed  CAS  Google Scholar 

  • Edelman, G.M. 1971. Antibody structure and molecular immunology. Ann. NY Acad. Sci. 31: 5–25.

    Article  Google Scholar 

  • Florio, M.A., Baldari, S., Fama, F., Giacobbe, G., and Pollicino, A. 2002. Radioimmunoguided sur gery (R.I.G.S.) in colorectal cancer. Preliminary results. Chir. Ital. 54: 323–329.

    Google Scholar 

  • Garcia Vicente, A., Soriano Castrejon, A., Gonzales, R., Rodado Marina, S., and Poblete Garcia, V.M. 2002. Comparative study of CEA antibody scan and computed tomography scan in the follow-up of patients with colorectal cancer. Rev. Esp. Med. Nucl. 21: 349–355.

    PubMed  CAS  Google Scholar 

  • Granowska, M., Jass, J.R., Britton, K.E., and Northover, J.M. 1989. A prospective study of the use of 111In-labelled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake. Int. J. Colorec. Dis. 4: 97–108.

    Article  CAS  Google Scholar 

  • Goldenberg, D.M., Blumenthal, R.D., and Sharkey, R.M. 1990. Biological and clinical perspectives of cancer imaging and therapy with radiolabeled antibodies. Cancer Biol. 1: 217–225.

    CAS  Google Scholar 

  • Goldenberg, D.M., Wlodkowski, T.J., Sharkey, R.M., Silberstein, E.B., Serafini, A.N., Garty, I.I., Van Heertum, R.L., Higginbotham-Ford, E.A., Kotler, J.A., Balasubramanian, N., Swayne, L.C., Hansen, H.J., and Pinsky, C.M. 1993. Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments. J. Nucl. Med. 34: 61–70.

    PubMed  CAS  Google Scholar 

  • Goldenberg, D.M. 1997. Perspectives on oncologic imaging with radiolabeled antibodies. Cancer 15: 431–435.

    Google Scholar 

  • Halpern, S.E., Carroll, R.G., and Tarbutron, J.P. 1988. Imaging with 111-In Fab' of an anti-CEA antibody: comparison with its 111-In intact and F(ab')2 derivative. J. Nucl. Med. 29: 812–818.

    Google Scholar 

  • Herry, J.Y., Bourguet, P., Kerbrat, P., Le Prise, E., Ben Hassel, M., Gedouin, D., and Richier, J.L. 1987. Immunoscintigraphy, an aid to the oncol-ogist-the Rennes experience in using anti-CEA, anti-CA 19.9 monoclonal antibodies and radiolabelled OC-125. Allerg. Immunol. (Paris). 19: 180–188.

    CAS  Google Scholar 

  • Hladik, P., Vizda, J., Bedrna, J., Simkovic, D., Strnad, L., Smejkal, K., and Voboril, Z. 2001. Immunoscintigraphy and intra-operative radio-immunodetection in the treatment of colorectal carcinoma. Colorect. Dis. 3: 380–386.

    Article  CAS  Google Scholar 

  • Holting, T., Schlag, P., and Georgi, P. 1990. Current status of immunoscintigraphy in colorectal can cer-results of 5 years' clinical experiences. Eur. J. Surg. Oncol. 16: 312–318.

    PubMed  CAS  Google Scholar 

  • Ito, K., Nakata, K., Watanabe, T., Hibi, K., Kasai, Y., Akiyama, S., and Takagi, H. 1997. Diagnosis of local recurrence of colorectal cancer, using PET and immunoscintigraphy by means of 131I or 111In anti-CEA monoclonal antibody. Nippon Geka Gakkai Zasshi 98: 373–379.

    PubMed  CAS  Google Scholar 

  • Larson, S.M., Carrasquillo, J.A., and Reynolds, J.C. 1984. Radioimmunodetection and radioimmu-notherapy. Cancer Invest. 2: 363–381.

    Article  PubMed  CAS  Google Scholar 

  • Lechner, P., Lind, P., Snyder, M., and Haushofer, H. 2000. Probe-guided surgery for colorectal can cer. Recent Results. Cancer Res. 157: 273–280.

    CAS  Google Scholar 

  • Leitha, T., Baur, M., Steger, G., and Dudczak, R. 1990. Anti-CEA immunoscintigraphy in postoperative follow-up of tumor patients. Differentiated use of various monoclonal anti body preparations. Wien. Klin. Wochenschr. 14: 503–509.

    Google Scholar 

  • Liehn, J.C., Hannequin, P., Nasca, S., Lebrun, D., Fernandez-Valoni, A., and Valeyre, J. 1989. Immunoscintigraphy with indium-111 labeled monoclonal antibodies: the importance of a good display method. Clin. Nucl. Med. 14: 187–191.

    Article  PubMed  CAS  Google Scholar 

  • Lunniss, P.J., Skinner, S., Britton, K.E., Granowska, M., Morris, G., and Northover, J.M. 1999. Effect of radioimmunoscintigraphy on the management of recurrent colorectal cancer. Br. J. Surg. 86: 244–249.

    Article  PubMed  CAS  Google Scholar 

  • Moffat, F.L., Gulec, S.A., Serafini, A.N., Sfakianakis, G.N., Pop, R., Robinson, D.S., Franceschi, D., Boggs, J., and Livingstone, A.S. 1999. A thousand points of light or just dim bulbs? Radiolabeled antibodies and colorectal cancer imaging. Cancer Invest. 17: 322–334.

    Article  PubMed  Google Scholar 

  • Murphy, G.P., Lawrence, W. Jr., and Lenhard, R.E. Jr. 1995. Textbook of Clinical Oncology. 2nd ed. Atlanta, Ga: American Cancer Society Muxi Pradas, M.A., Pons Pons, F., Huguet Planella, M., Novell Capilla, F., Garcia-Romero, R. H., and Trias Folch, M. 1996. Immunogammagraphy with anti-CEA and anti-TAG-72 monoclonal antibodies in the diagnosis of colorectal carci noma. Med. Clin. (Barc) 107: 601–617.

    Google Scholar 

  • Muxi Pradas, M.A., Pons Pons, F., Huguet Planella, M, Novell Capilla, F., Garcia-Romero, R.H., and Trias Folch, M. 1996. Immunogammagraphy with anti-CEA and anti-TAG-72 monoclonal antibodies in the diagnosis of colorectal carci noma. Med. Clin. (Barcelona) 107: 617–619.

    Google Scholar 

  • Nabi, H.A., Erb, DA., and Cronin, V.R. 1995. Superiority of SPET to planar imaging in the detection of colorectal carcinomas with 111In monoclonal antibodies. Nucl. Med. Commun. 16: 631–639.

    Article  PubMed  CAS  Google Scholar 

  • Neal, C.E., Johnson, D.L., Cornell, V.L., and Markwell, S. 1996. Quantitative analysis of In-111 satumomab pendetide immunoscinti-graphy. An aid to visual interpretation of images in patients with suspected carcinomatosis. Clin. Nucl. Med. 21: 638–642.

    Article  PubMed  CAS  Google Scholar 

  • Obradović, V., Artiko, V., Petrović, M., LauÅ¡ević, Ž., Stojković, M., Å obić-Å aranović, D., Petrović, N., Vlajković, M., and Krivokapić, Z. 2006. Scintigraphy of colorectal carcinomas with three different radiopharmaceuticals. Neoplasma 53: 444–449.

    PubMed  Google Scholar 

  • Oliva, J.P., Pimentel, G, Borron, M., Peralta, R., Ortiz, R., Oliver, B., Diaz, N., Sanchez, I., Vázquez, A.M., and Baum, R.P. 2001. Pilot study with the monoclonal antibody IOR-C5 as a potential agent of radioimmunoscintigraphy in colorectal cancer. Rev. Esp. Med. Nucl. 20: 282–288.

    PubMed  CAS  Google Scholar 

  • Oliva, J.P., Pimentel, G, Velasco, M., Martinez, A., Ortiz, R., Abreu, M., Diaz, N., Oliver, B., Sanchez, I., Valladares, T, and Baum, R.P 2005. Radio-immunodetection of colorectal cancer using Tc-99 m labeled monoclonal antobody ior-CEA1: Results of a Phase III Clinical Trial. World J. Nucl. Med. 3: 150–159.

    Google Scholar 

  • Oriuchi, N. 1999. Immunoscintigraphy and radi-oimmunotherapy of cancer using monoclonal antibodies. Gan. To. Kagaku. Ryoho. 26: 762–767.

    PubMed  CAS  Google Scholar 

  • Oriuchi, N., and Yang, D. 2001. Antibodies for tar geted imaging: Properties and radiolabeling. In: Kim, E.E., Yang, D.J., Eds. Targeted Molecular Imaging in Oncology: New York: Springer. pp. 83–87

    Google Scholar 

  • Poshyachinda, M., Chaiwatanarat, T., Saesow, N., Thitathan, S., and Voravud, N. 1996. Value of radioimmunoscintigraphy with technetium-99 m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal can cer. Eur. J. Nucl. Med. Mol. Imag. 23: 624–630.

    Article  CAS  Google Scholar 

  • Richman, P.I., and Bodmer, W.F. 1987. Monoclonal antibodies to human colorectal epithelium: mark ers for differentiation and tumour characteriza tion. Int. J. Cancer 39: 317–328.

    Article  PubMed  CAS  Google Scholar 

  • Riva, P., Moscatelli, G., Agostini, M., Spinelli, A., and Franceschi, G. 1989. Immunoscintigraphy of primary and metastatic colorectal cancers with radiolabelled monoclonal antibodies anti-CEA. Acta Gastroenterol. Belg. 52: 497–505.

    PubMed  CAS  Google Scholar 

  • Ryan, J.W. 1993. Immunoscintigraphy in primary colorectal cancer. Cancer 71: 4217–4224.

    Article  PubMed  CAS  Google Scholar 

  • Salvatore, M., Lastoria, S., Del Vecchio, S., and Mansi, L. 1989. Detection of colon cancer with radiolabelled monoclonal antibodies. Int. J. Rad. Appl. Instrum. B. 16: 103–104.

    PubMed  CAS  Google Scholar 

  • Schlag, P., Holting, T., Steinbacher, M., Kretzschmar, U., and Georgi, P. 1987. Current role of immuno-scintigraphy for surgical therapy of the recurrence of colorectal cancers. Chirurg. 58: 594–596.

    PubMed  CAS  Google Scholar 

  • Sirisriro, R., Boonkitticharoen, V., Kraiphibul, P., Ratanatharathorn, V., Sumboonnanon, K., Kanjanapitak, A., Kuhapremma, T., Sritara, C., Puchinda, D., Chouplywech, P., Jalayondeja, V., Pekanan, P., Rochanawutanon, M., Intaramarn, C., Ayudhya, A.N., and Chokesuwathana, P. 2000. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99 mTc scintigraphy. Hepatogastroenterology 47: 405–513.

    PubMed  CAS  Google Scholar 

  • Tempero, M. 1993. Pitfalls in antibody imaging in colorectal cancer. Cancer 71: 4248–4251.

    Article  PubMed  CAS  Google Scholar 

  • Volpe, C.M., Abdel-Nabi, H.H., Kulaylat, M.N., and Doerr, R.J. 1998. Results of immunoscin-tigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer. Ann. Surg. Oncol. 5: 489– 494.

    Article  PubMed  CAS  Google Scholar 

  • Willkomm, P., Bender, H., Bangard, M., Decker, P., Grünwald, F., and Biersack, H.J. 2000. FDG PET and immunoscintigraphy with 99 mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. J Nucl. Med. 41: 1657–1663.

    PubMed  CAS  Google Scholar 

  • Winzelberg, G.G., Grossman, S.J., Rizk, S., Joyce, J.M., Hill, J.B., Atkinson, D.P., Sudina, K., Anderson, K., McElwain, D., and Jones, A.M. 1992. Indium-111 monoclonal antibody B72.3 scintigraphy in colorectal cancer: correlation with computed tomography, surgery, histopa-thology, immunohistology and human immune response. Cancer 69: 1656–1663.

    Article  PubMed  CAS  Google Scholar 

  • Wong, J.Y.C., Ghu, D.Z., Williams, L.E., Yamauchi, D.M., Ikle, D.N., Kwok, C.S., Liu, A., Wilczynski, S., Colcher, D., Yazaki, P.J., Shively, J.E., Wu, A.M., and Raubitschek, A. 2004. Pilot Trial Evaluating an 123I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal Cancer. Clin. Cancer Res. 10: 5014–5021.

    Article  PubMed  CAS  Google Scholar 

  • Ychou, M., Rougier, P., Bidart, J.M., Bellet, D., Tigaud, J.M., and Bohuon, C. 1989. The value of tumor markers in digestive oncology. Ann. Chir. 43: 517–523.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Nuclear Medicine, Clinical Center of Serbia, Belgrade University School of Medicine, Višegradska 26, Belgrade, 11000, Serbia

    Obradović Vladimir & Artiko Vera

Authors
  1. Obradović Vladimir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Artiko Vera
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Biological Sciences, Kean University, Union, NJ, USA

    M. A. Hayat

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science + Business Media B.V.

About this chapter

Cite this chapter

Vladimir, O., Vera, A. (2009). Metastases and Recurrence of Colorectal Cancer: Diagnostic Role of Immunoscintigraphy. In: Hayat, M.A. (eds) Colorectal Cancer. Methods of Cancer Diagnosis, Therapy, and Prognosis, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9545-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4020-9545-0_4

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-1-4020-9544-3

  • Online ISBN: 978-1-4020-9545-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation